Pathology Analysis & Statistics, September 2014

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Publishers

All regions

You might be interested in: cancer, breast cancer, leukemia, more »

1-50 of about 407 000 reports

Purchase Reports From Reputable Market Research Publishers

Future Horizons and Growth Strategies in the European Tumor Marker Testing Market 2014: Supplier Shares and Country Forecasts

Future Horizons and Growth Strategies in the European Tumor Marker Testing Market 2014: Supplier Shares and Country Forecasts

  • $ 12 800
  • Industry report
  • August 2014
  • by Venture Planning Group

This unique report provides information not available from any other published source, including volume, sales, and leading supplier shares by test. This comprehensive five-country report identifies and ...

  • Industries : Pathology
  • Countries : Europe
Analysis of the Global Infectious Disease Diagnostics Market

Analysis of the Global Infectious Disease Diagnostics Market

  • $ 10 000
  • Industry report
  • September 2014
  • by Frost & Sullivan

Molecular Methods Present Significant Opportunities This deliverable provides research and analysis of the global infectious disease diagnostics market. It includes an in-depth analysis of revenue forecast ...

  • Industries : Pathology
  • Countries : World
OpportunityAnalyzer: Non-Hodgkin's B-Cell Lymphoma - Opportunity Analysis and Forecast to 2018

OpportunityAnalyzer: Non-Hodgkin's B-Cell Lymphoma - Opportunity Analysis and Forecast to 2018

  • $ 7 995
  • Industry report
  • August 2014
  • by Global Data

OpportunityAnalyzer: Non-Hodgkin's B-Cell Lymphoma - Opportunity Analysis and Forecast to 2018 Summary The competitive landscape in the B-cell NHL markets in the US, France, Italy, Germany, Spain and the ...

  • Industries : Pathology
  • Countries : United States
OpportunityAnalyzer: Cystic Fibrosis - Opportunity Analysis and Forecasts to 2018 - Event-Driven Update

OpportunityAnalyzer: Cystic Fibrosis - Opportunity Analysis and Forecasts to 2018 - Event-Driven Update

  • $ 7 995
  • Industry report
  • July 2014
  • by Global Data

OpportunityAnalyzer: Cystic Fibrosis - Opportunity Analysis and Forecasts to 2018 - Event-Driven Update Summary Cystic Fibrosis (CF) is an autosomal recessive disease characterized by the secretion of ...

  • Industries : Pathology
  • Countries : United States
OpportunityAnalyzer: Chronic Lymphocytic Leukemia - Opportunity Analysis and Forecasts to 2018

OpportunityAnalyzer: Chronic Lymphocytic Leukemia - Opportunity Analysis and Forecasts to 2018

  • $ 7 995
  • Industry report
  • June 2014
  • by Global Data

OpportunityAnalyzer: Chronic Lymphocytic Leukemia - Opportunity Analysis and Forecasts to 2018 Summary Chronic lymphocytic leukemia (CLL), the most common form of adult leukemia, is caused by the uncontrolled ...

  • Industries : Pathology
Frontier Pharma: Breast Cancer - Identifying and Commercializing First-in-Class Innovation

Frontier Pharma: Breast Cancer - Identifying and Commercializing First-in-Class Innovation

  • $ 6 995
  • Industry report
  • July 2014
  • by GBI Research

Frontier Pharma: Breast Cancer - Identifying and Commercializing First-in-Class Innovation Summary Exceptionally Large and Innovative Pipeline The breast cancer pipeline is the largest in the pharmaceutical ...

  • Industries : Pathology
Autoimmune Disease Diagnostics: Global Markets

Autoimmune Disease Diagnostics: Global Markets

  • $ 6 650
  • Industry report
  • September 2014
  • by BCC Research

This BCC Research report estimates the global diagnostics market for autoimmune diseases, with CAGR projections for the period 2014 to 2019. Market size estimates for pre-treatment and during-treatment ...

  • Industries : Pathology
  • Countries : World
Blood-Brain Barrier Technologies and Global Markets

Blood-Brain Barrier Technologies and Global Markets

  • $ 6 650
  • Industry report
  • July 2014
  • by BCC Research

This BCC Research report analyzes the current status of the global therapeutic market for blood-brain barrier (BBB) technologies, including its growth potential, determines its current market status, examines ...

  • Industries : Pathology
  • Countries : World
Payer Insights: Hepatitis C

Payer Insights: Hepatitis C

  • $ 6 495
  • Industry report
  • September 2014
  • by Firstword Pharma

The race is on for the company that can competitively price treatment regimens, share data on clinical benefit/positioning and support patient initiatives. Payer Insights: Hepatitis C, based on in-depth ...

  • Industries : Pathology
  • Countries : United States
BCC Research Bitopertin Forecast

BCC Research Bitopertin Forecast

  • $ 5 500
  • Industry report
  • August 2014
  • by BCC Research

This BCC Research forecast report provides quantitative data about the pharmaceutical drug, Bitopertin. The report will help potential customers in making strategic decisions regarding future participation ...

  • Industries : Pathology
Non-Hodgkin Lymphoma Therapeutics in Asia-Pacific Markets to 2020 - Novel Technologies Show Considerable Promise in Relapsed/Refractory Setting

Non-Hodgkin Lymphoma Therapeutics in Asia-Pacific Markets to 2020 - Novel Technologies Show Considerable Promise in Relapsed/Refractory Setting

  • $ 4 995
  • Industry report
  • September 2014
  • by GBI Research

Non-Hodgkin Lymphoma Therapeutics in Asia-Pacific Markets to 2020 - Novel Technologies Show Considerable Promise in Relapsed/Refractory Setting Summary GBI Research, the leading business intelligence provider, ...

  • Industries : Pathology
  • Countries : World, Australia, India, Japan, China
Human Microbiome Market by Disease (Diabetes, Obesity, Autoimmune, Cancer, Diarrhea, Mental Disorder), Application (Therapeutic, Diagnostic) & by Product (Probiotic, Prebiotic, Food, Medical Food, Supplement, Device, Drug) - Global Forecast to 2023

Human Microbiome Market by Disease (Diabetes, Obesity, Autoimmune, Cancer, Diarrhea, Mental Disorder), Application (Therapeutic, Diagnostic) & by Product (Probiotic, Prebiotic, Food, Medical Food, Supplement, Device, Drug) - Global Forecast to 2023

  • $ 4 650
  • Industry report
  • September 2014
  • by MarketsandMarkets

Need for early diagnosis and efficient treatment with microbiome therapy for maintaining healthy lifestyle will boost the human microbiome market The product segment is expected to account for the largest ...

  • Industries : Pathology
  • Countries : World
Automotive Occupant Sensing System (OSS) and Whiplash Protection System (WPS) Market for Passenger Cars - by Geography - Trends and Forecasts 2014 - 2019

Automotive Occupant Sensing System (OSS) and Whiplash Protection System (WPS) Market for Passenger Cars - by Geography - Trends and Forecasts 2014 - 2019

  • $ 4 650
  • Industry report
  • August 2014
  • by MarketsandMarkets

Traditional passive safety systems such as airbags and seatbelts minimize the risk of injury in an accident. However, car makers are also focusing on the other passive safety systems like occupant sensing ...

  • Industries : Pathology
Western Blotting Market by Product (Instruments (Manual/Semi-automated/Automated), Consumables (Kits/Reagents/Membrane), by Application (Disease Diagnosis/Agriculture/Biomedical Research) - End-User Analysis & Global Forecast to 2018

Western Blotting Market by Product (Instruments (Manual/Semi-automated/Automated), Consumables (Kits/Reagents/Membrane), by Application (Disease Diagnosis/Agriculture/Biomedical Research) - End-User Analysis & Global Forecast to 2018

  • $ 4 650
  • Industry report
  • August 2014
  • by MarketsandMarkets

Over the years, the western blotting market, comprising of instruments and consumables, has witnessed various technological advancements to improve the sensitivity, reproducibility, quantifiability, and ...

  • Industries : Pathology
  • Countries : World
Digital Pathology Market by Slide Scanners (Whole Slide Imaging), Analytics (Image Analysis Software), Delivery Modes (Web Based/Cloud Based) & by Whole Slide Image Storage - Global Forecasts & Trends to 2018

Digital Pathology Market by Slide Scanners (Whole Slide Imaging), Analytics (Image Analysis Software), Delivery Modes (Web Based/Cloud Based) & by Whole Slide Image Storage - Global Forecasts & Trends to 2018

  • $ 4 650
  • Industry report
  • July 2014
  • by MarketsandMarkets

The global digital pathology market was valued at an estimated $250.2 million in 2013 and is expected to grow at a CAGR of 11.8%, to reach an estimated $437 million by 2018. In 2013, the North American ...

  • Industries : Pathology
  • Countries : World
A Global Product and Pipeline Analysis of Antiretroviral Drug Development for the Treatment of HIV/AIDS

A Global Product and Pipeline Analysis of Antiretroviral Drug Development for the Treatment of HIV/AIDS

  • $ 4 000
  • Industry report
  • July 2014
  • by Frost & Sullivan

Antiretroviral Combinations Continue to Transform the Treatment Landscape This research service focuses on antiviral/antiretroviral therapeutics for the treatment of HIV/AIDS. A product and pipeline assessment ...

  • Industries : Pathology
  • Countries : World
EpiCast Report: Asthma - Epidemiology Forecast to 2023

EpiCast Report: Asthma - Epidemiology Forecast to 2023

  • $ 3 995
  • Industry report
  • September 2014
  • by Global Data

EpiCast Report: Asthma - Epidemiology Forecast to 2023 Summary Asthma is a chronic inflammatory lung disease that affects persons of all ages, but most commonly starts in childhood. It is a common long-term ...

  • Industries : Pathology
EpiCast Report: Breast Cancer (HER2-, HER2+) - Epidemiology Forecast to 2023

EpiCast Report: Breast Cancer (HER2-, HER2+) - Epidemiology Forecast to 2023

  • $ 3 995
  • Industry report
  • September 2014
  • by Global Data

EpiCast Report: Breast Cancer (HER2-, HER2+) - Epidemiology Forecast to 2023 Summary Breast cancer is a malignant tumor that originates in the breast tissues. Most breast cancers are invasive tumors that ...

  • Industries : Pathology
  • Countries : Japan, World
EpiCast Report: Renal Cell Carcinoma - Epidemiology Forecast to 2023

EpiCast Report: Renal Cell Carcinoma - Epidemiology Forecast to 2023

  • $ 3 995
  • Industry report
  • August 2014
  • by Global Data

EpiCast Report: Renal Cell Carcinoma - Epidemiology Forecast to 2023 Summary Renal cell carcinoma (RCC) is a type of kidney cancer that originates in the lining of the proximal convoluted tubule, a part ...

  • Industries : Pathology
  • Countries : Japan, China, World, United States, Spain, Italy, France, Germany
Trends in Therapeutic Partnering

Trends in Therapeutic Partnering

  • $ 3 995
  • Industry report
  • August 2014
  • by Currentpartnering

The Trends in Therapeutic Partnering report provides the most comprehensive and in-depth insight into the 35 most popular therapeutic targets for partnering in the period 2009 to mid 2014. The report provides ...

  • Industries : Pathology
EpiCast Report: Acute Coronary Syndrome (ACS) - Epidemiology Forecast to 2023

EpiCast Report: Acute Coronary Syndrome (ACS) - Epidemiology Forecast to 2023

  • $ 3 995
  • Industry report
  • July 2014
  • by Global Data

EpiCast Report: Acute Coronary Syndrome (ACS) - Epidemiology Forecast to 2023 Summary Acute coronary syndrome (ACS) is a serious cardiovascular disease associated with high healthcare costs, frequent recurrences ...

  • Industries : Pathology
  • Countries : Germany, World, United States, Spain, United Kingdom, Italy, France, Japan
Medical Affairs Reputations in Oncology: Oncologists Rate Key Products and Companies

Medical Affairs Reputations in Oncology: Oncologists Rate Key Products and Companies

  • $ 3 900
  • Industry report
  • August 2014
  • by Firstword Pharma

As the oncology drug market continues to face significant road bumps in terms of development costs and pricing requirements, the role of Medical Affairs teams working with oncologists becomes ever more ...

  • Industries : Pathology
ASCO 2014 -- Delegate Physicians Rate Influence and Impact

ASCO 2014 -- Delegate Physicians Rate Influence and Impact

  • $ 3 900
  • Industry report
  • July 2014
  • by Firstword Pharma

Description Introduction What hit the market at ASCO 2014? Oncology has been, and remains, an area of significant commercial focus for the pharmaceutical industry. Favorable factors, such as cooperative ...

  • Industries : Pathology
Deal Terms in Alzheimer%s Disease 2000 - 2014

Deal Terms in Alzheimer%s Disease 2000 - 2014

  • $ 3 738
  • Industry report
  • July 2014
  • by Avance, Basel GmbH

The report "Alzheimer Deals 2000 - 2014" takes a detailed look at the deals that have been closed between biotechnology and pharmaceutical companies. Alzheimer's disease is a large potential market and ...

  • Industries : Pathology
Non-Small Cell Lung Cancer Market to 2020 - New Therapies to Enhance Treatment Segmentation and Drive Growth in an Increasingly Competitive Market

Non-Small Cell Lung Cancer Market to 2020 - New Therapies to Enhance Treatment Segmentation and Drive Growth in an Increasingly Competitive Market

  • $ 3 500
  • Industry report
  • July 2014
  • by GBI Research

Non-Small Cell Lung Cancer Market to 2020 - New Therapies to Enhance Treatment Segmentation and Drive Growth in an Increasingly Competitive Market Summary GBI Research, a leading business intelligence ...

  • Industries : Pathology
  • Countries : World
Brilinta (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023

Brilinta (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • July 2014
  • by Global Data

Brilinta (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Brilinta (Acute Coronary Syndrome) - Forecast and ...

  • Industries : Pathology
  • Countries : World, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe
Effient (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023

Effient (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • July 2014
  • by Global Data

Effient (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Effient (Acute Coronary Syndrome) - Forecast and ...

  • Industries : Pathology
  • Countries : World, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe
Crestor (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023

Crestor (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • July 2014
  • by Global Data

Crestor (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Crestor (Acute Coronary Syndrome) - Forecast and ...

  • Industries : Pathology
  • Countries : Japan, World, Spain, Italy, France, Germany, United States, United Kingdom, Europe
Xarelto (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023

Xarelto (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • July 2014
  • by Global Data

Xarelto (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Xarelto (Acute Coronary Syndrome) - Forecast and ...

  • Industries : Pathology
  • Countries : World, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe
Angiomax (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023

Angiomax (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • July 2014
  • by Global Data

Angiomax (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Angiomax (Acute Coronary Syndrome) - Forecast and ...

  • Industries : Pathology
  • Countries : World, United States, Spain, Italy, France, Germany, Japan, United Kingdom, Europe
About 40 000 reports

Download Unlimited Documents from Trusted Public Sources

Pathology Description in the US

  • National Gay Men's Hiv/aids Awareness Day - September 27, 2014
  • September 2014
    20 pages
  • Pathology  

    Hiv  

  • United States  

    North America  

View report >

Pathology Description

September 2014

Pathology Description

September 2014

Pathology Description

September 2014

About 100 Companies

Read our Company Profiles

Novartis Inc.

Switzerland

Johnson and Johnson

United States

GlaxoSmithKline P.L.C.

United States

C.R. Bard Inc.

United States

Covidien PLC

Ireland

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.